United Therapeutics
UTHR
#1100
Rank
$21.23 B
Marketcap
$469.49
Share price
0.38%
Change (1 day)
32.41%
Change (1 year)

Market capitalization of United Therapeutics (UTHR)

Market cap: $21.23 Billion USD

As of February 2026 United Therapeutics has a market cap of $21.23 Billion USD. This makes United Therapeutics the world's 1100th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of United Therapeutics from 1999 to 2026

End of year Market Cap

Year Marketcap Change
2026$21.23 B-7.43%
2025$22.93 B42.73%
2024$16.07 B55.52%
2023$10.33 B-18.47%
2022$12.67 B30.24%
2021$9.73 B44.26%
2020$6.74 B74.52%
2019$3.86 B-18.57%
2018$4.74 B-25.75%
2017$6.39 B5.09%
2016$6.08 B-15.11%
2015$7.16 B17.49%
2014$6.09 B7.06%
2013$5.69 B112.62%
2012$2.67 B-2.77%
2011$2.75 B-24.25%
2010$3.63 B27.46%
2009$2.85 B96.48%
2008$1.45 B-33.12%
2007$2.17 B86.06%
2006$1.16 B-27.56%
2005$1.61 B59.16%
2004$1.01 B107.06%
2003$0.48 B39.97%
2002$0.34 B65.96%
2001$0.21 B-30.15%
2000$0.30 B-59.06%
1999$0.73 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of United Therapeutics was reported to be:

$20.21 Billion USD
by Nasdaq info icon info icon
$21.23 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
$150.33 B 607.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$929.76 B 4,278.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
$10.31 B-51.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$176.13 B 729.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
$51.05 B 140.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$104.28 B 391.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
$7.72 B-63.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$39.09 B 84.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel